The company has reported a fall of 66.80% in its net profit at Rs 15.21 crore for the quarter under review as compared to Rs 45.82 crore for the same quarter in the previous year. However, total income of the company increased by 65.66% at Rs 278.50 crore for Q2FY19 as compared Rs 168.12 crore for the corresponding quarter previous year.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
